Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC

NCT05583188 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic

Conditions

NSCLC

Interventions

DEVICE: Aliya Pulsed Electric Fields (PEF) ablation
DRUG: Nivolumab plus Platinum Doublet Chemotherapy
DRUG: Standard of care neoadjuvant therapy
OTHER: Surgical Resection

Sponsor

Galvanize Therapeutics, Inc.